Akèy › Maladi Alzheimer › Illinois
Etid klinik pou Maladi Alzheimer nan Illinois
19 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan Illinois.
Vil nan Illinois
Tèks ofisyèl etid la (Anglè)
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Essential Concepts Research Solutions (ECRS), Palos Hills
Ap rekriteFaz 4
Laj 50 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07633470Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- RE:Cognition (Chicago), Chicago
- Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville, Chicago
Ap rekriteFaz 3
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Great Lakes Clinical Trials - Andersonville, Chicago
- Southern Illinois University School of Medicine, Springfield
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203OTC Hearing Aid and MCI
- Northwestern University HA Lab, Evanston
Ap rekrite
Laj 60 a 90 · Tout sèks · Mizajou Sep 4, 2026 · NCT06112860A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alexian Brothers Medical Center-Neurosciences ( Site 1017), Elk Grove Village
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Re:Cognition Health - Chicago, Chicago
- Ascension Alexian Brothers, Elk Grove Village
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
- Northwestern University Feinberg School of Medicine, Chicago
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07775625Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
Ap rekriteFaz 2/3Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05552157Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Insigth Hospital and Medical Center Chicago, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 90 · Tout sèks · Mizajou Jul 14, 2026 · NCT07701161A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Great Lakes Clinical Trials - Andersonville, Chicago
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582Communication Bridge 3 Study
- University of Chicago - American School Building, Chicago
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Jun 1, 2026 · NCT06191198Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Advocate Medical Group Adult Down Syndrome Center, Park Ridge
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109Late Onset Alzheimer's Disease
- Rush University, Aurora
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT05010603Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Flourish Research - Chicago, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 60 a 90 · Tout sèks · Mizajou Apr 15, 2026 · NCT06584357Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- Endeavor Health Systems, Evanston
Ap rekriteFaz 3Volontè an sante akeyi
Laj 45 ak plis · Tout sèks · Mizajou Jul 30, 2025 · NCT06254469Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
- Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences, Chicago
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Jun 5, 2025 · NCT07005895Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Full List of Active Sites, Chicago
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Dec 14, 2023 · NCT06170268Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.